Silence Therapeutics plc
SLNCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$50 | -$47 | -$46 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $4 |
| Stock-Based Comp. | $16 | $13 | $10 | $9 |
| Change in WC | -$33 | -$12 | -$8 | $39 |
| Other Non-Cash | -$6 | $3 | -$1 | $0 |
| Operating Cash Flow | -$68 | -$39 | -$45 | $7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | -$10 |
| Inv. Purchases | -$139 | -$21 | -$16 | $10 |
| Inv. Sales/Matur. | $117 | $36 | $0 | $10 |
| Other Inv. Act. | $0 | $1 | $0 | $0 |
| Investing Cash Flow | -$22 | $16 | -$17 | $9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$0 |
| Stock Issued | $142 | $25 | $43 | $31 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $43 | $31 |
| Financing Cash Flow | $142 | $25 | $43 | $31 |
| Forex Effect | $0 | -$3 | $0 | -$0 |
| Net Chg. in Cash | $53 | -$1 | -$19 | $46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69 | $55 | $74 | $27 |
| End Cash | $121 | $54 | $55 | $74 |
| Free Cash Flow | -$68 | -$39 | -$46 | $5 |